Aztreonam-avibactam therapy following surgical source control for bla NDM -positive carbapenem-resistant Klebsiella pneumoniae intra-abdominal infection in an infant: a case report
Abstract
Treating carbapenem-resistant Klebsiella pneumoniae (CRKP) is challenging, particularly when resistance is mediated by New Delhi metallo-β-lactamase (NDM). Clinical experience with fixed-combination aztreonam-avibactam (ATM-AVI) in young infants remains extremely limited. Here, we report a case of a 2-month-old boy who underwent emergency laparotomy for intestinal obstruction owing to small bowel volvulus with segmental necrosis, followed by bowel resection and reanastomosis. His postoperative course was complicated by respiratory failure, coagulopathy, septic shock, recurrent abdominal distension, and massive ascites. Blood cultures were negative, whereas metagenomic next-generation sequencing of blood detected K. pneumoniae and Enterococcus faecium. Owing to the worsening of his condition, diagnostic paracentesis and repeat laparotomy were performed, revealing an anastomotic leak. Intraoperative pus culture yielded bla NDM -positive CRKP. The isolate was resistant to carbapenems and ceftazidime-AVI but was susceptible to ATM-AVI, with a minimum inhibitory concentration of ≤4 mg/L. ATM-AVI was administered at 30 mg/kg every 8 h, based on the aztreonam component, for 14 days; linezolid and fluconazole were co-administered as part of the broader anti-infective regimen. The combination of definitive surgical source control, targeted antimicrobial therapy, and comprehensive intensive care successfully controlled the infection and stabilized his hemodynamics. The patient…
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population-based study
- Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China
- The Role of the NLR and PLR in Urinary Tract Infection
- Threat of Antimicrobial Resistance among Pilgrims with Infectious Diseases during Hajj: Lessons Learnt from COVID-19 Pandemic
- Leclercia adecarboxylata urinary tract infection in a patient with bladder cancer and recurrent hematuria
- A Case Series of Staphylococcus lugdunensis Infection in Cancer Patients at an Academic Cancer Institute in the United States
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.